Literature DB >> 17382376

Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine.

Cindy S Roegge1, Charles Perraut, Xin Hao, Edward D Levin.   

Abstract

Histamine H(1) blockade is one of the more prominent actions of the multi-receptor acting antipsychotic clozapine. It is currently not known how much this H(1) antagonism of clozapine contributes to the therapeutic or adverse side effects of clozapine. The current studies with Sprague-Dawley rats were conducted to determine the participation of histaminergic H(1) receptor subtype in sensorimotor plasticity and memory function affected by clozapine using tests of prepulse inhibition (PPI) and radial-arm maze choice accuracy. The PPI impairment caused by the glutamate antagonist dizocilpine (MK-801) was significantly attenuated by clozapine. In the current project, we found that the selective H(1) antagonist pyrilamine also reversed the dizocilpine-induced impairment in PPI of tactile startle with an auditory prepulse. In the radial-arm maze (RAM), pyrilamine, like clozapine, impaired working memory and caused a significant dose-related slowing of response. Pyrilamine, however, decreased the number of reference memory errors. We have previously shown that nicotine effectively attenuates the clozapine-induced working memory impairment, but in the current study, nicotine did not significantly alter the effects of pyrilamine on the RAM. In summary, the therapeutic effect of clozapine in reversing PPI impairment was mimicked by the H(1) antagonist pyrilamine, while pyrilamine had a mixed effect on cognition. Pyrilamine impaired working memory but improved reference memory in rats. Thus, H(1) antagonism seems to play a role in part of the beneficial actions of antipsychotics, such as clozapine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382376      PMCID: PMC2699266          DOI: 10.1016/j.pbb.2007.02.014

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  48 in total

1.  Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats.

Authors:  C Taga; Y Sugimoto; M Nishiga; Y Fujii; C Kamei
Journal:  Eur J Pharmacol       Date:  2001-07-06       Impact factor: 4.432

2.  Therapeutic advantages of third generation antihistamines.

Authors:  D A Handley; A Magnetti; A J Higgins
Journal:  Expert Opin Investig Drugs       Date:  1998-07       Impact factor: 6.206

3.  Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats.

Authors:  E Nakazato; T Yamamoto; M Ohno; S Watanabe
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

4.  Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.

Authors:  Nii Addy; Edward D Levin
Journal:  Neuropsychopharmacology       Date:  2002-10       Impact factor: 7.853

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

6.  Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia.

Authors:  Edward D Levin; N Channelle Christopher
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-12-13       Impact factor: 5.067

7.  Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.

Authors:  Gerard B Fox; Timothy A Esbenshade; Jia Bao Pan; Richard J Radek; Kathleen M Krueger; Betty B Yao; Kaitlin E Browman; Michael J Buckley; Michael E Ballard; Victoria A Komater; Holly Miner; Min Zhang; Ramin Faghih; Lynne E Rueter; R Scott Bitner; Karla U Drescher; Jill Wetter; Kennan Marsh; Martine Lemaire; Roger D Porsolt; Youssef L Bennani; James P Sullivan; Marlon D Cowart; Michael W Decker; Arthur A Hancock
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

8.  Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

Authors:  R S Mansbach; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1989-12       Impact factor: 7.853

9.  The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia.

Authors:  T E Goldberg; R D Greenberg; S J Griffin; J M Gold; J E Kleinman; D Pickar; S C Schulz; D R Weinberger
Journal:  Br J Psychiatry       Date:  1993-01       Impact factor: 9.319

10.  Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats.

Authors:  Maryam Eidi; Mohammad-Reza Zarrindast; Akram Eidi; Shahrbanoo Oryan; Kazem Parivar
Journal:  Eur J Pharmacol       Date:  2003-03-28       Impact factor: 4.432

View more
  7 in total

Review 1.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-09-02       Impact factor: 4.530

3.  Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.

Authors:  Marie Humbert-Claude; Elisabeth Davenas; Florence Gbahou; Ludwig Vincent; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2011-09-13       Impact factor: 4.530

4.  The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-06-28       Impact factor: 4.530

5.  Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition.

Authors:  José A Larrauri; Lisalynn D Kelley; Mason R Jenkins; Eric C Westman; Nestor A Schmajuk; M Zachary Rosenthal; Edward D Levin
Journal:  Neuropsychopharmacology       Date:  2013-09-18       Impact factor: 7.853

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Effects of Manipulation of Noradrenergic Activities on the Expression of Dopaminergic Phenotypes in Aged Rat Brains.

Authors:  Fei Zeng; Yan Fan; Russell W Brown; Wesley Drew Gill; Jennifer B Price; Thomas C Jones; Meng-Yang Zhu
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.